ABSTRACT Aim: Continuous pain occurs routinely, even after invasive procedures, or inflammation and surgery, but clinical practices associated with assessments of continuous pain remain unknown.
INTRODUCTION
All newborns experience acute episodic pain or prolonged, continuous pain during admission to neonatal intensive care units (NICUs) (1, 2) . Untreated neonatal pain prolongs human suffering and is often associated with short-term and long-term physical, behavioural, or cognitive sequelae (3, 4) . Conversely, some analgesic drugs can prolong mechanical ventilation (5) , delay feedings (6) or impair brain growth and development (7) (8) (9) . Pain needs to be assessed before treatment, but neonatal pain assessments are time-and labour-intensive and difficult to implement in routine NICU care (10) (11) (12) .
Bedside nurses make global pain assessments or apply validated pain assessment tools before treating a newborn's pain or discomfort (13, 14) , but NICU workloads may not allow bedside nurses to assess pain regularly. Most neonatal pain scales were designed to measure acute pain from skinbreaking procedures; these scales may not be clinically relevant for measuring continuous pain (15) . Assessments of the continuous pain that follows invasive procedures, or inflammation and surgery, may enhance the quality of pain management, avoid untreated pain vs. unnecessary analgesia, prevent under-or overdosing of analgesics, or development of drug tolerance (16) (17) (18) .
Continuous pain may be defined as pain lasting beyond the initial episode that causes tissue injury (19) , mucosal stimulation (20) or inflammation (4, 21) . Attempts to define chronic or continuous pain in newborns have not led to consistent or clinically useful definitions (16, 17) . Identifying continuous pain is important because it may interfere with infant growth, prolong hospitalisation, alter subsequent pain perception and impair cognitive and behavioural development (4, 17) . Few methods, however, were designed to assess continuous pain (15, (22) (23) (24) and the application of assessment methods designed using acute pain models to clinical assessments of continuous pain remains controversial (25) .
We hypothesized that continuous pain is not assessed routinely during NICU care, but may be assessed more frequently among neonates receiving mechanical ventilation than in neonates breathing spontaneously. Our objectives were to study the frequency of bedside assessments for continuous pain as well as the individual and institutional factors determining the use of these assessments in routine NICU care. We report assessments of continuous pain in 6648 neonates studied in 243 NICUs from 18 European countries.
METHODS

Study design
European-pain-audit-in-neonates (EUROPAIN) was a prospective observational study of clinical practices related to sedation/analgesia and was designed using STROBE guidelines (26) . The website (www.europainsurvey.eu) stored multilingual study materials, instructive videos on completing online questionnaires, documents, progress reports and the complete study protocol (http://www. europainsurvey.eu/europain-survey-protocol/). Website links connected authorised users to secure servers (hosted by Voozanoo â ; Epiconcept, Paris, France) for data entry into standardised questionnaires.
Participating centres NICU nurses or physicians volunteered as National Principal Investigators (NPIs); each NPI invited participation of all NICUs in their country and provided data on national pain guidelines for neonates. Level III NICUs initiating and performing the full period of mechanical ventilation were eligible for participation; NICUs unable to provide the full range of Level III care were not eligible. A study nurse, data quality manager and physician coordinator were appointed for each unit, providing information on NICU characteristics and local sedation/analgesia protocols. NICUs were queried about the presence of nurses or physicians with specialised knowledge and/or commitment to neonatal pain management; these clinicians were labelled as physician or nurse pain champions.
Data collection
During prespecified enrolment periods, all NICU admissions up to 44 weeks postconceptual age were included. Demographic data, modes of ventilation, use of continuous or intermittent sedation/analgesia or neuromuscular blockers, and assessments of continuous pain for each neonate were collected prospectively during the first 28 days of NICU admission, or until death, or hospital discharge. NICUs were specifically asked to record pain assessments performed with pain tools designed for measuring prolonged, continuous pain; two examples of these scales were given on the data collection sheets [e.g. Echelle Douleur Inconfort Nouveau-n e (EDIN) scale, COMFORT scale] and NICU staff could record any other pain scales they used for continuous pain. Data collection occurred for one month in all participating NICUs; enrolment periods were staggered such that less than forty (40) NICUs enrolled patients concomitantly, allowing the coordinating centre to closely monitor data collection at each site. Subject recruitment was authenticated via the NICU admissions logbook. As the study focus was continuous pain (not procedural pain), we specifically collected data on pain assessments carried out with continuous pain tools, recorded which assessment tools were used, and the number of assessments per day. Newborns were included in the pain-assessed group if at least one assessment of continuous pain occurred during their entire NICU stay. NICUs were included in the pain-assessed group if any assessments of continuous pain were recorded from that unit.
Data quality assurance A centralised team in Paris monitored completeness and relevance of the data collection. Missing or incongruous data were reported to unit coordinators and locally doublechecked. The monitoring team randomly selected 10% of subjects (minimum five patients) and the local data quality manager completely double-checked all these patients. If 1% or more errors occurred, data from another 10% subjects were double-checked; if 1% error rates persisted, all data entries from that NICU were double-checked.
Regulatory compliance
Study protocols and data collection were first approved by the regulatory bodies for Protection of Human Subjects, Data Protection, and Health Research Data Management in France and then approved by similar committees in each country and at some participating sites. Information sheets were given to parents to explain the de-identified data collection, and they were free to decline their child's participation. In some countries (e.g. Norway), parents were required to give consent for participation. The study was registered at ClinicalTrials.gov (#NCT01694745).
Sample size
Sample size calculations were based on sedation/analgesia practices (27) . We anticipated the participation of at least 15 countries and planned to make comparisons between all countries. We used a chi-square power analysis to calculate the sample size. We expected small differences in sedation or analgesia practices between countries, estimating an effect size (W) of 0. 
RESULTS
Study population
From October 1, 2012, to June 30, 2013, we enrolled 6648 neonates eligible for this study (Fig. 1) . Highest levels of ventilation during the study period classified patients into tracheal ventilation (TrV, n = 2138), noninvasive ventilation (NiV, n = 1493) and spontaneous ventilation groups (NoV, n = 3017); patient characteristics are listed in Table 1 and their distribution among participating countries is listed in Across participating countries, pain assessments for continuous pain ranged from 6% to 90% in the TrV group, from 0% to 87% in the NiV group and from 0% to 84% in the NoV group (Table 2) . On average, individual newborns received 0.8 to 6.7 pain assessments per day (Table 2) .
Moreover, many different tools were used to assess continuous pain; the EDIN scale was used most frequently (1199/ 2113, 56.7%); other scores used commonly included the COMFORTneo behaviour scale (19.7%), the N-PASS (Neonatal Pain, Agitation and Sedation Scale; 13.2%), and the COMFORT scale (10.1%) (Table S2) .
NICU characteristics NICU characteristics increasing the assessment of continuous pain included the availability of local guidelines, physician or nurse champions, pain consult services, number of surgical admissions and ventilator-days per year (univariable analyses; Table 3 ). Multivariable GEE models using country as a cluster showed that local pain assessment guidelines (OR: 3.96), nurse pain champions (OR: 2.54) and surgical admissions (OR: 1.01) prompted greater use of continuous pain assessments (all p < 0.01).
Newborn characteristics
In univariable analyses, patient characteristics influencing pain assessments in all neonates were as follows: gestational age, birthweight, outborn status, age at admission, Clinical Risk Index for Babies scores (CRIB), one-minute and fiveminute Apgar scores, intubation at admission, surgical condition, respiratory distress syndrome, ventilation status, use of O-SH-GA drugs and hospital length of stay (Table 4) . Multivariable modelling using NICUs as cluster showed higher odds of pain assessments associated with prematurity (24-29 weeks OR: 1.92; 30-32 weeks OR: 2.11, both p < 0.001), intubation at admission (OR: 1.97, p < 0.001), need for surgery (OR: 2.14, p = 0.028), noninvasive ventilation (OR: 1.88, p < 0.001) and use of O-SH-GA drugs (OR: 1.99, p < 0.001), but lower odds with inborn status (OR: 0.67, p = 0.023) and higher CRIB scores (OR: 0.95, p = 0.013) ( Table 4 ). More frequent pain assessments occurred specifically on those patient-days associated with TrV (42.3% vs. 25.5%, p < 0.001) or the use of O-SH-GA drugs (45.6% vs. 26.4%, p < 0.001) (Fig. 2) .
Among tracheally ventilated newborns, patient characteristics influencing continuous pain assessments in univariable analyses included outborn status, CRIB scores, five-minute Apgar scores, intubation at admission, surgical condition, respiratory distress syndrome, use of O-SH-GA and duration of mechanical ventilation. Multivariable GEE modelling showed that the odds of pain assessments increased with intubation at admission (OR: 2.00, p < 0.001) and O-SH-GA use (OR: 1.45, p = 0.008), but decreased with higher CRIB scores (OR: 0.93, p = 0.001) ( Figure 1 Flow chart of the countries invited, the participating NICUs ('units'), patients assessed and those enrolled in this study. All neonates with pain assessment outcome data were included in our analyses; missing data were not imputed.
Are pain assessments associated with sedation/analgesia in ventilated newborns?
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DISCUSSION
Statement of principal findings
We report the first international, prospective observational study investigating neonatal pain assessment practices in European NICUs. Neonatal pain guidelines recommend routine pain assessments scheduled every 4-6 hours each day (30, 31) , but only 10% of neonates received daily assessments of continuous pain. More than two-thirds of all neonates and more than half of tracheally ventilated neonates received no assessments of continuous pain during their entire NICU stay! This reveals a significant gap between recommended (30,31) and bedside practices for neonatal pain assessment. Pain assessments varied from 0% to 100% across the three ventilation groups, the 243 NICUs, and the 18 countries; therefore, we identified the individual and institutional characteristics associated with pain assessments. We used GEE methods for multivariable analyses to incorporate binary and continuous data, weighted and nonweighted observations, as well as more complex interactions between the variables in our database (32) . NICUs with local pain management guidelines, nursing champions, and increased surgical admissions performed assessments of continuous pain more frequently. Pain assessments also occurred more frequently among newborns <32 weeks gestational age, those requiring surgery, mechanical ventilation, use of opioids (morphine, fentanyl, sufentanil), sedatives-hypnotics (midazolam, lorazepam, barbiturates) or general anaesthetics (ketamine, propofol) in the NICU. Assessments of continuous pain in ventilated neonates were more likely on the patient-days associated with use of opioids, sedatives/hypnotics or general anaesthetics (Fig. 2 ).
Strengths and weaknesses of this study
Assessments of continuous pain were associated with greater severity of illness, because they occurred more frequently in newborns with extreme prematurity, those requiring intubation at admission, or surgical interventions, or tracheal and noninvasive ventilation during their NICU stay. Neonates with higher CRIB scores, however, had less frequent pain assessments. This discrepancy may occur because the CRIB score was designed to measure risk of mortality from clinical factors at the time of NICU admission (33) , and it does not reflect severity of illness during the entire NICU stay. Pain assessments occurred more frequently following use of O-SH-GA drugs among all neonates, tracheally ventilated neonates and noninvasively ventilated neonates. Pain assessments were also more likely on the patient-days when these drugs were used (Fig. 2) . Even among newborns receiving continuous infusions of O-SH-GA drugs, however, only 48% had assessments of continuous pain on the same day or the day after starting these drugs. To limit the data collection burden on participating NICUs, the timing of pain assessments or drug administration was not recorded; therefore, our data do not permit more detailed analyses of the relationships between pain assessments and therapeutic decision-making.
Another limitation could be that participating NICUs do not represent national practices in each country. Because of differences in the number of participating NICUs (and subjects) across the different countries (Table S1 ), we performed sensitivity analyses to weight the pain assessment results with the proportion of neonates enrolled per 10 000 live births in each country. The results of these analyses were substantially unchanged, thus suggesting external validity for the European countries participating in this study. While we acknowledge this limitation, other than mandatory data collection (often with suspect data quality), we had no practical options to overcome this limitation. Level III NICUs with relatively high patient volumes participated in all countries, not only representing a snapshot of the most advanced practices in each country, but also allowing us to sample on average about 0.15% of all births per year (Table S1) .
A putative 'Hawthorne effect' (34) could have altered pain assessment practices during study enrolment, but this would be difficult to maintain during 24/7 data collection over a one-month period. Another limitation is that these results were based on documentation of bedside pain assessments. NICU nurses may rigorously record the use of pain medications, whereas pain assessments and nonpharmacological interventions may be recorded less rigorously. Many NICUs require the regular charting of bedside pain scores every 4-6 hours with the patient's vital signs. Data collection occurred from any existing record, including patient notes, nursing flowsheet at bedside or other sources. We believe that all pain assessments occurring at the bedside were recorded in our data collection. Despite the aforementioned limitations, this is the largest study to date, using prospective data collection, robust data quality assurance, enrolling 94% of all eligible neonates, accounting for all nonenrolled neonates, while overcoming the language, cultural and research regulatory barriers in 18 countries. Thus, it represents the most comprehensive glimpse into the current bedside pain assessment practices in NICUs.
Strengths and weaknesses in relation to other studies NICU nurses are primarily responsible for bedside pain assessments in neonates although some have questioned the utility (35) and validity (36) of these assessments. An alternative approach calls for using pain scores for research studies and pain detection for clinical care (37) , but it still does not address the need for assessing continuous pain. Well-known weaknesses in the current paradigm for neonatal pain assessments include their subjectivity, low inter-rater reliability and other concerns (10, 15, 18, (38) (39) (40) . Sedatives and neuromuscular blockers may also mask the behavioural signs of continuous pain (27) . Despite the weaknesses and caveats of neonatal pain assessment tools, we posit that routine assessments of continuous pain will improve individualised pain management (18, 41) .
Of the currently available pain assessment tools, only the EDIN (22) , COMFORTneo (24), ALPS-Neo (Astrid Lindgren's Children's Hospital Pain Scale) (23) and the Neonatal Pain, Agitation and Sedation Scale (N-PASS) (42) were designed to assess continuous pain. To develop the EDIN scale, a panel of experts assessed video recordings of neonates with prolonged pain (e.g. necrotising enterocolitis, postoperative pain) for behavioural indicators of pain (facial activity, body movements, quality of sleep, quality of contact with nurses, consolability). It showed acceptable inter-rater reliability, high internal consistency and significant differences between painful and nonpainful conditions, suggesting preliminary construct validity (22) . van Dijk et al. adapted COMFORT scale to develop the COMFORTneo scale for newborns with prolonged pain, which appeared to be a promising tool but requires additional studies to support its validity and clinical utility (24) . Similarly, Lundqvist et al. adapted the ALPS-1 scale to develop the ALPS-Neo using five behavioural parameters, including facial expressions, breathing pattern, limb muscle tone, hand/foot activity and level of activity to assess continuous pain in neonates (23) . They reported acceptable reliability and face validity, although this tool also requires further validation (23) . The N-PASS was designed to assess pain and sedation in neonates with postoperative pain or mechanical ventilation and showed adequate inter-rater reliability, convergent and discriminate validity (42) , and clinical utility (43) . It was later applied to acute pain with similar results (44) . Despite the availability of these scales, continuous pain lacks a consistent definition.
Pillai-Riddell et al. (16) interviewed experienced clinicians to define chronic pain in infancy. Their qualitative analysis suggested that inability to settle, social withdrawal, constant grimacing, tense body, hypo-or hyper-reactivity to acute pain, dysregulated sleep or feeding patterns could serve as potential indicators for chronic pain. Secondary analyses from the NEOPAIN trial suggested that facial expressions of pain, high activity levels, poor response to handling and poor ventilator synchronicity were most frequently associated with continuous pain in preterm newborns ≤32 weeks of gestation (15) . Although both studies found some overlap with EDIN parameters, they were not used to develop novel assessment tools for persistent pain in neonates.
Although the PIPP and CRIES scales have been tested in settings of postoperative pain, their construct validity as tools to assess continuous pain remains unproven (25, 45) . Our finding of infrequent assessments of continuous pain is not surprising in the context of few assessment tools available and relative lack of across-the-board validity data for these methods (18, 41) . Furthermore, the validity of these scales when translated into the different languages spoken in the participating countries has not been established.
Meaning of the study Infrequent and highly variable assessments of continuous pain in newborns may contribute to analgesic complications (46) , oversedation (47) or tolerance/withdrawal (48) . Given the limitations and controversies reviewed above, the variability noted in this study is not unexpected and mirrors similar findings in adult patients (49) . Our data show that local NICU guidelines and local nurse champions substantially increased the odds for pain assessment, whereas the availability of pain consult services did not (Table 3 ). All NICUs should develop standardised approaches for neonatal pain and identify experienced nurses to lead this effort. Most NICUs had local neonatal pain guidelines, but only a third of the participating countries had national guidelines. Policymakers at the European Medicines Agency and/or European professional societies should consider developing neonatal pain guidelines for NICUs in all European countries. Odds ratio per point increase in CRIB score. The CRIB score is a measure of illness severity in neonates. It consists of six items collected in the first 12 hours after birth (range: 0-23, higher scores indicate great clinical risk of mortality). ‡ ‡ Data collection was stopped on day 28 of hospital stay: 566 (28.4%) of 1994 neonates were hospitalised for longer than 28 days. § § Ventilator-free days were defined as the number of calendar days from the time of tracheal extubation to day 28 after NICU admission. If a neonate was reintubated and subsequently extubated before day 28, ventilator-free days were counted from the end of the last period of tracheal intubation. If a neonate was still receiving tracheal ventilation on day 28 or had died before day 28, then 0 ventilator-free days were noted. For neonates discharged before day 28 of admission, ventilator-free days were zero if the neonate was still intubated at discharge (transfer) and ventilator-free days were counted from the time of tracheal extubation to day 28 after NICU admission if the neonate was already extubated at discharge.
Unanswered questions and future research
Neonatal pain research has been focused on the acute episodic pain associated with skin-breaking procedures (4, 11, 12, 36, 37, 50) . We suggest the need for a paradigm shift in neonatal pain research, paying greater attention to prolonged or continuous pain in newborns. First, we need to reach consensus on the taxonomy and definitions of various pain terms applied to neonates. Achieving consensus on these terms may lead to developing newer assessment tools, examining the validity and clinical utility of currently available and novel methods, and using these methods to determine the need for, and the efficacy of therapeutic approaches treating continuous pain in neonates. Neurophysiological approaches (51) such as near-infrared spectroscopy, electroencephalography or functional MRI can display pain-induced activity in the brain (2,52), whereas skin conductance, heart rate variability or pupillometry can detect autonomic activity in neonates (41, 53) . If these approaches lead to reliable and clinically useful pain measures, they may allow an independent validation of observer-dependent pain assessment scales for both episodic and continuous pain.
Recent guidelines from American Academy of Pediatrics state that validated pain assessment tools should be used consistently to initiate and monitor the effectiveness of analgesic interventions (30) . Reliable and objective measures of continuous pain in newborns must be defined, developed, extensively validated and used regularly at the bedside, to improve the safety and efficacy of analgesics or other therapies used for treating neonatal pain. By avoiding the acute and long-term effects of both unrelieved pain and unnecessary analgesia in newborns, we can optimise sedation/analgesia, improve clinical outcomes and reduce painrelated suffering in newborns.
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